![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: UBOX5 |
Gene summary for UBOX5 |
![]() |
Gene information | Species | Human | Gene symbol | UBOX5 | Gene ID | 22888 |
Gene name | U-box domain containing 5 | |
Gene Alias | RNF37 | |
Cytomap | 20p13 | |
Gene Type | protein-coding | GO ID | GO:0000209 | UniProtAcc | O94941 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
22888 | UBOX5 | LZE4T | Human | Esophagus | ESCC | 1.59e-02 | 9.99e-02 | 0.0811 |
22888 | UBOX5 | P2T-E | Human | Esophagus | ESCC | 5.42e-04 | 8.95e-02 | 0.1177 |
22888 | UBOX5 | P4T-E | Human | Esophagus | ESCC | 3.68e-03 | 7.01e-02 | 0.1323 |
22888 | UBOX5 | P8T-E | Human | Esophagus | ESCC | 1.68e-05 | 7.05e-02 | 0.0889 |
22888 | UBOX5 | P9T-E | Human | Esophagus | ESCC | 3.46e-04 | 8.37e-02 | 0.1131 |
22888 | UBOX5 | P10T-E | Human | Esophagus | ESCC | 4.79e-06 | 1.19e-01 | 0.116 |
22888 | UBOX5 | P11T-E | Human | Esophagus | ESCC | 4.08e-04 | 1.52e-01 | 0.1426 |
22888 | UBOX5 | P12T-E | Human | Esophagus | ESCC | 3.97e-08 | 1.50e-01 | 0.1122 |
22888 | UBOX5 | P15T-E | Human | Esophagus | ESCC | 1.50e-05 | 1.30e-01 | 0.1149 |
22888 | UBOX5 | P16T-E | Human | Esophagus | ESCC | 5.74e-10 | 1.55e-01 | 0.1153 |
22888 | UBOX5 | P17T-E | Human | Esophagus | ESCC | 1.24e-02 | 1.64e-01 | 0.1278 |
22888 | UBOX5 | P20T-E | Human | Esophagus | ESCC | 9.71e-05 | 1.11e-01 | 0.1124 |
22888 | UBOX5 | P21T-E | Human | Esophagus | ESCC | 3.96e-05 | 1.26e-01 | 0.1617 |
22888 | UBOX5 | P22T-E | Human | Esophagus | ESCC | 5.05e-03 | 4.40e-02 | 0.1236 |
22888 | UBOX5 | P23T-E | Human | Esophagus | ESCC | 2.55e-09 | 1.75e-01 | 0.108 |
22888 | UBOX5 | P24T-E | Human | Esophagus | ESCC | 3.67e-04 | 9.56e-02 | 0.1287 |
22888 | UBOX5 | P26T-E | Human | Esophagus | ESCC | 3.68e-28 | 4.88e-01 | 0.1276 |
22888 | UBOX5 | P28T-E | Human | Esophagus | ESCC | 4.16e-02 | 9.78e-02 | 0.1149 |
22888 | UBOX5 | P30T-E | Human | Esophagus | ESCC | 2.59e-03 | 2.19e-01 | 0.137 |
22888 | UBOX5 | P31T-E | Human | Esophagus | ESCC | 6.77e-06 | 1.63e-01 | 0.1251 |
Page: 1 2 3 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:000020917 | Esophagus | ESCC | protein polyubiquitination | 170/8552 | 236/18723 | 1.40e-16 | 1.09e-14 | 170 |
GO:000020921 | Liver | HCC | protein polyubiquitination | 151/7958 | 236/18723 | 1.90e-11 | 7.59e-10 | 151 |
Page: 1 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0412027 | Esophagus | ESCC | Ubiquitin mediated proteolysis | 122/4205 | 142/8465 | 6.53e-20 | 7.29e-18 | 3.74e-18 | 122 |
hsa0412036 | Esophagus | ESCC | Ubiquitin mediated proteolysis | 122/4205 | 142/8465 | 6.53e-20 | 7.29e-18 | 3.74e-18 | 122 |
hsa0412041 | Liver | HCC | Ubiquitin mediated proteolysis | 110/4020 | 142/8465 | 1.67e-13 | 3.74e-12 | 2.08e-12 | 110 |
hsa0412051 | Liver | HCC | Ubiquitin mediated proteolysis | 110/4020 | 142/8465 | 1.67e-13 | 3.74e-12 | 2.08e-12 | 110 |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
UBOX5 | SNV | Missense_Mutation | rs780072656 | c.1493C>T | p.Pro498Leu | p.P498L | O94941 | protein_coding | deleterious(0.02) | benign(0.357) | TCGA-AX-A2HC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | paclitaxel | PD |
UBOX5 | SNV | Missense_Mutation | rs139376372 | c.431N>T | p.Ala144Val | p.A144V | O94941 | protein_coding | tolerated(0.34) | benign(0.006) | TCGA-AX-A2HD-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | III/IV | Unknown | Unknown | SD |
UBOX5 | SNV | Missense_Mutation | rs771115445 | c.1082N>G | p.Ser361Cys | p.S361C | O94941 | protein_coding | deleterious(0.01) | benign(0.091) | TCGA-AX-A2IO-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Chemotherapy | carboplatin | SD |
UBOX5 | SNV | Missense_Mutation | rs201389796 | c.1589C>T | p.Pro530Leu | p.P530L | O94941 | protein_coding | tolerated(0.21) | benign(0.005) | TCGA-AX-A3G8-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
UBOX5 | SNV | Missense_Mutation | c.1086G>T | p.Gln362His | p.Q362H | O94941 | protein_coding | tolerated(0.56) | benign(0.125) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD | |
UBOX5 | SNV | Missense_Mutation | rs374361254 | c.73G>A | p.Glu25Lys | p.E25K | O94941 | protein_coding | deleterious(0) | possibly_damaging(0.859) | TCGA-B5-A0JY-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | doxorubicin | SD |
UBOX5 | SNV | Missense_Mutation | novel | c.1315N>A | p.Leu439Ile | p.L439I | O94941 | protein_coding | deleterious(0.01) | probably_damaging(0.991) | TCGA-B5-A1MX-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Hormone Therapy | megace | SD |
UBOX5 | SNV | Missense_Mutation | novel | c.848T>A | p.Val283Asp | p.V283D | O94941 | protein_coding | deleterious(0.01) | probably_damaging(0.997) | TCGA-B5-A3FC-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
UBOX5 | SNV | Missense_Mutation | rs752379442 | c.1606N>A | p.Val536Met | p.V536M | O94941 | protein_coding | deleterious(0.01) | possibly_damaging(0.72) | TCGA-BS-A0VI-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
UBOX5 | SNV | Missense_Mutation | c.136N>C | p.Phe46Leu | p.F46L | O94941 | protein_coding | deleterious(0) | probably_damaging(0.996) | TCGA-D1-A103-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |